Equities

Deltex Medical Group PLC

DEMG:LSE

Deltex Medical Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)0.1075
  • Today's Change0.005 / 4.88%
  • Shares traded15.20m
  • 1 Year change-90.23%
  • Beta0.7518
Data delayed at least 20 minutes, as of Mar 28 2024 17:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Deltex Medical Group PLC (DEMG:LSE) closed at 0.1075, 19.44% above the 52 week low of 0.09 set on Mar 26, 2024.
52-week range
Today
0.09Mar 26 20241.60May 04 2023
Open0.1025
High0.155
Low0.155
Bid0.09
Offer0.115
Previous close0.1025
Average volume5.73m
Shares outstanding1.90bn
Free float625.39m
P/E (TTM)--
Market cap2.04m GBP
EPS (TTM)-0.0015
GBP
Data delayed at least 20 minutes, as of Mar 28 2024 17:08 BST.
More ▼

Investor Relations Contact

General Enquiries

For general enquiries, or if you are a shareholder who wishes to have additional copies of the Report and Accounts, Interim Statements, presentations etc., please contact:

Paul Mitchell
Company Secretary

Deltex Medical Group plc
Terminus Road
Chichester
West Sussex
PO19 8TX
Tel: +44 (0)1243 774837
Fax: +44 (0)1243 532534

Administrative Enquiries

Queries concerning shareholdings in Deltex Medical Group plc, such as the loss of share certificate, dividend payments, or change of address should be directed, in the first instance, to the registrar:

Capita Registras
The Registry
34 Beckenham Road
Beckenham
Kent
BR3 4TU
Tel: 08701 623100 (within the UK)
Calls cost 10p a minute plus network extras,
lines are open 8.30am-5.30pm Mon-Fri

Tel: +44 (0)20 8639 2157
Fax: +44 (0)20 8639 2342

Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.